Anti-angiogenic properties of a sulindac analogue

Neuroscience

• Angiopoietin 1 100%
• Angiopoietin Receptor 100%
• Sulindac 100%
• In Vivo 66%
• In Vitro 66%
• Vascular Endothelial Growth Factor 66%
• Angiogenesis 66%
• Human Umbilical Vein Endothelial Cell 66%
• Growth Factor 33%
• Mitogen-Activated Protein Kinase 33%
• Kinase 33%
• Protein Kinase B 33%
• Fibrinogen 33%
• Receptor Phosphorylation 33%
• Basic Fibroblast Growth Factor 33%
• Cell Migration 33%
• Matrigel 33%
• Acetate 33%
• MTT Assay 33%
• Angiopoietin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiopoietin Receptor 100%
• Angiopoietin 1 100%
• Antiangiogenic 100%
• Sulindac 100%
• Vasculotropin 66%
• Growth Factor 33%
• Receptor 33%
• Phosphotransferase 33%
• Mitogen Activated Protein Kinase 33%
• Fibrinogen 33%
• Potassium Acetate 33%
• Fibroblast Growth Factor 2 33%
• Protein Kinase B 33%
• Matrigel 33%
• Neovascularization (Pathology) 33%
• Angiopoietin 33%

Keyphrases

• Sulindac 100%
• Antiangiogenic Properties 100%
• C-18 100%
• Angiopoietin 40%
• Tie-2 Receptor 30%
• Vascular Endothelial Growth Factor 20%
• Incubation 20%
• Human Umbilical Vein Endothelial Cells (HUVECs) 20%
• Signaling Pathway 10%
• Growth Factors 10%
• In Vitro Experiment 10%
• Endothelial Cells 10%
• Mitogen-activated Protein Kinase 10%
• Induced Response 10%
• Dose Effect 10%
• Angiogenesis 10%
• Concentration-dependent 10%
• Fibroblast Growth factor-2 (FGF-2) 10%
• Bromo 10%
• Methyl 10%
• Neovascularization 10%
• Acetic Acid 10%
• Induced Proliferation 10%
• Kinase Assay 10%
• Receptor Activity 10%
• Matrigel 10%
• New Blood Vessel 10%
• Chicken Chorioallantoic Membrane 10%
• Kinase Family 10%
• Blood Vessel Formation 10%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 10%
• Receptor Phosphorylation 10%
• Endothelial Cell Migration 10%
• MTT Assay 10%
• Migration Assay 10%
• Boyden Chamber 10%
• Structure Formation 10%
• Tube Type 10%
• Benzylidene 10%